Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FAWCU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,439
Award facts
- Contract value 100% obligated
- $10,438.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for KESIMPTA 20 mg/0.4 mL pen injections valued at $10,438.96. The award, issued on August 22, 2025, is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a direct supply of pharmaceutical products to support Department of Defense healthcare operations. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on a competitive basis despite its small business status. The place of performance is listed as Conshohocken, Pennsylvania.
This delivery order falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The underlying IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs at military health facilities worldwide. KESIMPTA (ofatumumab) is a monoclonal antibody used in the treatment of certain autoimmune conditions, and this order represents a specific draw-down against the company's broader pharmaceutical supply agreement with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB25FAWCU?
SPE2DB25FAWCU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FAWCU worth?
The government has obligated $10,439 on SPE2DB25FAWCU.
Is contract SPE2DB25FAWCU an order under another contract?
Yes. SPE2DB25FAWCU is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWCU competed?
The extent of competition for SPE2DB25FAWCU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award